Emily L. Nelson

The Safety, Plasma Pharmacokinetics, and Antiviral Activity of Subcutaneous Enfuvirtide (T-20), a Peptide Inhibitor of gp41-Mediated Virus Fusion, in HIV-Infected Adults

J Michael Kilby, Jacob Lalezari, Joseph J. Eron et al. · AIDS Research and Human Retroviruses · 2002 · 198 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Characterization of determinants of genotypic and phenotypic resistance to enfuvirtide in baseline and on-treatment HIV-1 isolates

Prakash Sista, Tom Melby, Donna K. Davison et al. · AIDS · 2004 · 154 citations

Life Sciences, Infectious Diseases, Molecular Biology +17

A phase II clinical study of the long-term safety and antiviral activity of enfuvirtide-based antiretroviral therapy

Jacob Lalezari, Joseph J. Eron, Margrit Carlson et al. · AIDS · 2003 · 149 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacology +17

Long-Term Treatment with Subcutaneous T-20, a Fusion Inhibitor, in HIV-Infected Patients: Patient Satisfaction and Impact on Activities of Daily Living

C Cohen, Alex Dusek, J. Green et al. · AIDS Patient Care and STDs · 2002 · 38 citations

Pharmacy, Immunology, Pharmacotherapy +16